Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease ; volume:10 ; number:1 ; day:26 ; month:2 ; year:2018 ; pages:1-14 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (26.2.2018), 1-14, 12.2018

Urheber
Beteiligte Personen und Organisationen
Traschütz, Andreas
Widmann, Catherine N.
Kummer, Markus P.
Tacik, Pawel
Santarelli, Francesco
Jessen, Frank
Heneka, Michael T.
SpringerLink (Online service)

DOI
10.1186/s13195-018-0353-3
URN
urn:nbn:de:101:1-2018091001180111495571
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Brosseron, Frederic
  • Traschütz, Andreas
  • Widmann, Catherine N.
  • Kummer, Markus P.
  • Tacik, Pawel
  • Santarelli, Francesco
  • Jessen, Frank
  • Heneka, Michael T.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimer disease pathology and the cerebrospinal fluid proteome

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Verbundene Objekte